Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,062.70
-14.10 (-1.31%)
At close: Jan 19, 2026
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 573.71 billion as of January 16, 2026. Its market cap has increased by 76.52% in one year.
Market Cap
573.71B
Enterprise Value
596.47B
Revenue
63.58B
Ranking
n/a
PE Ratio
83.90
Stock Price
1,062.70
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 573.71B, an increase of 1,109.38%. That is a compound annual growth rate of 31.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 573.71B | -4.09% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.00T |
| Divi's Laboratories | 1.66T |
| Cipla | 1.12T |
| Apollo Hospitals Enterprise | 1.03T |
| Mankind Pharma | 898.02B |
| Zydus Lifesciences | 873.51B |
| Alkem Laboratories | 697.84B |
| Aurobindo Pharma | 681.11B |